mRNA |
AMG-706 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.7 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |